Literature DB >> 11510204

[In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].

C González1, A García, F Daroch, F Kawaguchi, H Solar, N Rivera, E Vega.   

Abstract

BACKGROUND: Our laboratory has carried out an epidemiological surveillance of Helicobacter pylori antimicrobial susceptibility since 1997. AIM: To report the antimicrobial susceptibility of H pylori strains, isolated in Chile from August 1997 to August 2000.
MATERIAL AND METHODS: Ninety one H pylori strains, obtained from antral gastric biopsies during upper gastrointestinal endoscopies were studied. Susceptibility towards clarithromycin, amoxicillin, bismuth subcitrate and metronidazole was studied by an agar diffusion technique.
RESULTS: All strains were susceptible to amoxicillin and two strains were resistant to clarithromycin. Forty two percent of strains were resistant to metronidazole and 13% were resistant to bismuth subcitrate.
CONCLUSIONS: These results underscore the need to maintain an epidemiological surveillance of H pylori antimicrobial susceptibility, to modify its eradication therapy accordingly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11510204

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  6 in total

1.  In vitro effect of amoxicillin and clarithromycin on the 3' region of cagA gene in Helicobacter pylori isolates.

Authors:  Javier Andrés Bustamante-Rengifo; Andrés Januer Matta; Alvaro Pazos; Luis Eduardo Bravo
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

2.  Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile.

Authors:  Arnoldo Riquelme; Alejandro Soza; Cesar Pedreros; Andrea Bustamante; Felipe Valenzuela; Francisco Otarola; Eduardo Abbott; Marco Arellano; Brenda Medina; Alejandro Pattillo; Douglas Greig; Marco Arrese; Antonio Rollan
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

3.  Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.

Authors:  Adalucy Alvarez; José Ignacio Moncayo; Jorge Javier Santacruz; Mario Santacoloma; Luisa Fernanda Corredor; Elizabeth Reinosa
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

4.  Isolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern chile.

Authors:  Laura Otth; Myra Wilson; Heriberto Fernández; Carola Otth; Claudio Toledo; Victoria Cárcamo; Paula Rivera; Luis Ruiz
Journal:  Braz J Microbiol       Date:  2011-06-01       Impact factor: 2.476

5.  High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis.

Authors:  A Arenas; C Serrano; L Quiñones; P Harris; M Sandoval; M Lavanderos; R Sepúlveda; S Maquilón; A Echeverría; C Ríos; E Fuentes-López; L Rojas; A Jorquera; M Pizarro; M C Camargo; A Riquelme
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

6.  Prevalence of Infection and Antibiotic Susceptibility of Helicobacter pylori: An Evaluation in Public and Private Health Systems of Southern Chile.

Authors:  Marcelo Oporto; Monica Pavez; Claudia Troncoso; Alvaro Cerda; Edmundo Hofmann; Armando Sierralta; Eddy Rios; Luis Coppelli; Leticia Barrientos
Journal:  Pathogens       Date:  2019-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.